

You can get tirzepatide (Mounjaro/Zepbound) from Eli Lilly & Co; which is a combined GLP-1- and GIP-agonist, and is slightly more efficacious than semaglutide (Ozempic/Wegovy) for weight loss. The main reasons to choose semaglutide over tirzepatide is if the patient has established cardiovascular disease without diabetes, because there is evidence for it reducing the risk of major cardiovascular events in that population; or if the patient really prefers a pill to an injectable.
The point being… there are alternatives to Ozempic in the US by American companies. I also think you mean “substitute”, not “subsidize”.


It’s time to take this seriously, I think. Every time Trump throws a tantrum and starts threatening a trade war, the European leaders come out and say that they’re concerned. And “Oh my! This behavior is not becoming of an American president.” This is what American foreign policy looks like now. We should end our reliance on American digital services as soon as possible.